G. Shalviri

发表

Matrix of drug quality reports in USAID-assisted countries by the U.S. Pharmacopeia Drug Quality and Information Program.

S. Hill, S. Rai, M. Mathai, 2006 .

Adverse reactions of anti‐tuberculosis drugs in hospitalized patients: incidence, severity and risk factors

K. Gholami, G. Shalviri, J. Salamzadeh, 2007, Pharmacoepidemiology and drug safety.

Drug Safety Crises Management in Pharmacovigilance

R. Majdzadeh, K. Gholami, G. Shalviri, 2017 .

Adverse events induced by ceftriaxone: a 10‐year review of reported cases to Iranian Pharmacovigilance Centre

K. Gholami, G. Shalviri, S. Yousefian, 2012, Journal of clinical pharmacy and therapeutics.

Pediatric hospital admission due to adverse drug reactions: Report from a tertiary center

Fatemeh Babaie, K. Gholami, G. Shalviri, 2015, Journal of research in pharmacy practice.

The evaluation of isotretinoin induced adverse drug reactions

K. Gholami, G. Shalviri, J. Salamzadeh, 2011 .

Fatalities following skin exposure to arsenic

G. Shalviri, S. Khosravi, A. Cheraghali, 2007, Clinical toxicology.

Pattern of use and Adverse Drug Reactions of Tramadol; A Review of 336, 610, 664 Insured Prescriptions During 5 Years

M. Abdollahi, G. Shalviri, F. Soleymani, 2011 .

Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients

K. Gholami, E. Kamali, M. Hajiabdolbaghi, 2006, Pharmacy practice.

Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach

R. Majdzadeh, K. Gholami, G. Shalviri, 2015, Implementation Science.

Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients

M. Salarifar, K. Gholami, G. Shalviri, 2010, Pharmacoepidemiology and drug safety.

Cytotoxic Glucose Degradation Products in Fluids for Peritoneal Dialysis

G. Shalviri, H. Hajimehdipoor, M. Shekarchi, 2011, Iranian journal of pharmaceutical research : IJPR.

New guideline for tramadol usage following adverse drug reactions reported to the Iranian pharmacovigilance center

G. Shalviri, S. Yousefian, K. Gholami, 2007, Pharmacoepidemiology and drug safety.

Developing an adverse drug reaction reporting system at a teaching hospital.

G. Shalviri, F. Fahimi, Shadi Baniasadi, 2008, Basic & clinical pharmacology & toxicology.

Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database

R. Majdzadeh, K. Gholami, G. Shalviri, 2007, Pharmacoepidemiology and drug safety.

Ten Years Pharmacovigilance Activities in Iran

R. Dinarvand, G. Shalviri, M. Valadkhani, 2009 .

Medication Without Harm

G. Shalviri, 2023, Journal of Pharmaceutical Care.

Factors Associated with Preventability, Predictability, and Severity of Adverse Drug Reactions

K. Gholami, G. Shalviri, K Gholami, 1999, The Annals of pharmacotherapy.

Improving adverse drug event reporting by health care professionals

R. Majdzadeh, K. Gholami, G. Shalviri, 2017 .

Choosing Appropriate Theories for Understanding Hospital Reporting of Adverse Drug Events, a Theoretical Domains Framework Approach

R. Majdzadeh, K. Gholami, G. Shalviri, 2018, Iranian journal of pharmaceutical research : IJPR.

Adverse drug reactions induced by cardiovascular drugs in outpatients

K. Gholami, G. Shalviri, S. Ziaie, 2008, Pharmacy practice.

Anti‐infectives‐induced adverse drug reactions in hospitalized patients

M. Sharifzadeh, K. Gholami, G. Shalviri, 2005, Pharmacoepidemiology and drug safety.